Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
The independent source for health policy research, polling, and news.
1,321-1,340 of 1,723 results
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Stephanie Armour of The Wall Street Journal and Rebecca Adams of CQ Roll Call discuss how Medicare, Medicaid and the fate of the Affordable Care Act are playing out in the politics of the coming midterm elections. Plus, Rovner interviews Matt Eyles, president and CEO of America’s Health Insurance Plans.
The Trump administration is pulling out an old regulation that it believes will be able to meet a key conservative goal: withholding some federal funding for Planned Parenthood in the government’s family planning program.
The White House’s latest immigration strategy has created challenges for the HHS Office of Refugee Resettlement, which is now responsible for more children — many far younger than in previous administrations.
President Trump relied heavily on testing as protection against COVID exposure, eschewing masks and social distancing.
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Sarah Kliff of Vox and Alice Ollstein of Talking Points Memo discuss a proposed administration regulation that seeks to separate Planned Parenthood from federal family planning funds, the final congressional passage of legislation aimed at helping those with terminal illnesses obtain experimental medications, and new government reports on the uninsured and federal health spending. Also, Rovner interviews KHN’s Liz Szabo about the May “Bill of the Month.”
Some public health officials fear that the Trump administration’s proposals to change how Title X funding is handled may impede the effort to cut the record number of sexually transmitted diseases.
Federal officials say loosening the regulation of these plans will offer small businesses a more affordable health insurance option, but critics are wary.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.
The academics insist that more workers should get top-rated N95 masks, the best defense against airborne coronavirus particles.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children’s Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
With the primary now over, health care may well emerge as an issue that helps voters distinguish between candidates for governor, attorney general and other offices in the general election.
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
President-elect Joe Biden inherits a global health landscape changed by the Trump administration more than under any Republican president since Ronald Reagan.
Local health officials have become the face of government authority as they work to stem the pandemic. That has made them targets for chilling threats from some of the same militia groups that stormed the U.S. Capitol. Santa Cruz leaders are among those whose daily routines now incorporate security patrols, surveillance cameras and, in some cases, firearms.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
© 2026 KFF